HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 2.00
Day range
GBX 2.00 - GBX 2.50
Year range
GBX 1.06 - GBX 12.85
Market cap
18.93M GBP
Avg Volume
2.96M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 4.38M | 203.33% |
Operating expense | 10.78M | 22.64% |
Net income | -10.34M | 40.33% |
Net profit margin | -236.41 | 80.33% |
Earnings per share | — | — |
EBITDA | -9.84M | -23.35% |
Effective tax rate | -0.52% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.95M | 309.99% |
Total assets | 48.80M | 83.33% |
Total liabilities | 33.77M | 68.21% |
Total equity | 15.03M | — |
Shares outstanding | 782.06M | — |
Price to book | 1.00 | — |
Return on assets | -50.69% | — |
Return on capital | -70.12% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -10.34M | 40.33% |
Cash from operations | -8.62M | -108.65% |
Cash from investing | -556.00K | -13.01% |
Cash from financing | 9.76M | 125.71% |
Net change in cash | 177.00K | -32.44% |
Free cash flow | -6.35M | -26.23% |
About
CEO
Founded
2008
Website
Employees
73